FDA Adverse Event Injury Summary report: N

REMISOL ADVANCE

MDR report key: 7949512 · Received October 9, 2018

Report

Report Number
3006543086-2018-01000
Event Type
Injury
Date Received
October 9, 2018
Date of Event
June 29, 2018
Report Date
September 10, 2018
Manufacturer
NORMAND-INFO S.A.S.U.
Product Code
JQP
UDI-DI
13700962600938
PMA / PMN Number
EXEMPT
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

NORMAND TECHNICAL SUPPORT AND AN INFORMATICS TECHNICAL SPECIALIST REVIEWED THE ISSUE, AND OBSERVED THE AUTO-VALIDATION STOPPING COMMENT LINKED TO FERRITIN WAS REMOVED WHEN THE RESULT WAS DELETED. THEN WHEN THE SAMPLE WAS RERUN, THIS COMMENT WAS NOT RECREATED BECAUSE THE RULE THAT GENERATED IT WAS CONFIGURED TO PLAY ONCE. THIS LED TO THE FERRITIN RESULT BEING AUTO-VALIDATED AS THE AUTO-VALIDATION RULE WAS UNABLE TO FIND THE MISSING COMMENT. THE CAUSE OF THE ISSUE IS ATTRIBUTED TO USE ERROR DUE TO AN INCORRECT RULE AND THE CUSTOMER DELETING A RESULT. THE ISSUE WAS RESOLVED BY MODIFYING THE RULE IN REMISOL AND DISCUSSING THE CORRECT MANAGEMENT OF THE FAILURE AND RESULTS WITH THE CUSTOMER. (B)(4).

Description of Event or Problem · 1

THE CUSTOMER REPORTED THEIR REMISOL AUTO-VALIDATED AN ERRONEOUS PATIENT RESULT FOR FERRITIN. THE ERRONEOUS RESULT WAS AUTO-RELEASED OUT OF THE LABORATORY. THE PHYSICIAN STOPPED TREATMENT FOR A PATIENT BASED ON THE ERRONEOUS RESULT. PATIENT TREATMENT WAS RESUMED UPON NOTIFICATION OF THE ISSUE. NO SPECIFIC DETAILS OF THE PATIENT TREATMENT WERE PROVIDED. THERE WAS NO REPORT OF HARM TO THE PATIENT. NO DETAILS WERE PROVIDED IN REGARDS TO THE INSTRUMENT USED TO RUN THE PATIENT SAMPLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
786952 REMISOL ADVANCE REMISOL ADVANCE JQP NORMAND-INFO S.A.S.U. NA NA 13700962600938

Patients

Seq Age Sex Outcome Treatment
1 47 YR Other